SV Tech Ventures is a Palo Alto-based venture capital firm that invests early-stage startups with great potential. Our team includes seasoned technology industry experts who have extensive experience in both entrepreneurship and investing across various fields. We work closely with our portfolio companies to help them with business strategy, product development, fundraising, and talent acquisition. We also have a vast network of industry contacts that we can introduce startups to, which can accelerate their growth. Our goal is to build long-term partnerships with our portfolio companies and support them through every stage of their journey.
Since then, we have completed investments in over 80 high-tech high-touch companies through SV Tech Fund I, II and III. Most recent exits include This is L (Organic Personal Care Acquired by Procter & Gamble), Original Stitch Inc (Custom Shirts. Acquired by World Co.), NeuroVasc(Mechanical thrombectomy solution for brain revascularization. Acquired), and Turning Point Therapeutics (Targeted Cancer therapies. Publicly traded on Nasdaq), Arrinex(Medical Device Acquired by Stryker), Neuvector(Full lifecycle container security platform), Oculli(High resolution virtual AI software for image radar), Apexgen(clinical-stage biopharmaceutical company).
At SV Tech Ventures, we believe in companies that develop advanced technologies with high barriers to entry and market leadership positions. These breakthroughs are born from innovation and have the potential to make significant impacts on industries and society.